AVR 0.99% $15.30 anteris technologies ltd

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-327

  1. 527 Posts.
    lightbulb Created with Sketch. 51
    Lex, we are under presser at this particular time so take a breath, and let me put a smile on your face.Before the 3Q 2017, i gave same numbers, They are ADMEDUS is at 18M turnover W.P said that we will hit 21M wich makes 50% growth before the 3Q I said ADMEDUS will hit 75% growth that is 24.5M so Lex please have a better look 75% grouth and a big future in ADAPT
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.